University of Chicago Cancer Research Center
University of Chicago Cancer Research Center
Chicago, Illinois, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma | Relapsed Classic Hodgkin Lymphoma | Recruiting | Phase 2 | 2026-09-22 | NCT04561206 |